Mounjaro

Mounjaro is the brand name for injectable tirzepatide manufactured by Eli Lilly, FDA-approved for the treatment of type 2 diabetes. It's dosed weekly and acts as a dual agonist on both GLP-1 and GIP receptors. It shares its active ingredient with Zepbound, which is approved specifically for weight management.